Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology - PubMed
Review
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology
Fabio Malavasi et al. Physiol Rev. 2008 Jul.
Free article
Abstract
The membrane proteins CD38 and CD157 belong to an evolutionarily conserved family of enzymes that play crucial roles in human physiology. Expressed in distinct patterns in most tissues, CD38 (and CD157) cleaves NAD(+) and NADP(+), generating cyclic ADP ribose (cADPR), NAADP, and ADPR. These reaction products are essential for the regulation of intracellular Ca(2+), the most ancient and universal cell signaling system. The entire family of enzymes controls complex processes, including egg fertilization, cell activation and proliferation, muscle contraction, hormone secretion, and immune responses. Over the course of evolution, the molecules have developed the ability to interact laterally and frontally with other surface proteins and have acquired receptor-like features. As detailed in this review, the loss of CD38 function is associated with impaired immune responses, metabolic disturbances, and behavioral modifications in mice. CD38 is a powerful disease marker for human leukemias and myelomas, is directly involved in the pathogenesis and outcome of human immunodeficiency virus infection and chronic lymphocytic leukemia, and controls insulin release and the development of diabetes. Here, the data concerning diseases are examined in view of potential clinical applications in diagnosis, prognosis, and therapy. The concluding remarks try to frame all of the currently available information within a unified working model that takes into account both the enzymatic and receptorial functions of the molecules.
Similar articles
-
Ikeda T, Takasawa S, Noguchi N, Nata K, Yamauchi A, Takahashi I, Yoshikawa T, Sugawara A, Yonekura H, Okamoto H. Ikeda T, et al. Mol Cell Biochem. 2012 Jul;366(1-2):69-80. doi: 10.1007/s11010-012-1284-0. Epub 2012 Mar 16. Mol Cell Biochem. 2012. PMID: 22422046
-
The ADP-ribosyl cyclases--the current evolutionary state of the ARCs.
Ferrero E, Lo Buono N, Horenstein AL, Funaro A, Malavasi F. Ferrero E, et al. Front Biosci (Landmark Ed). 2014 Jun 1;19(6):986-1002. doi: 10.2741/4262. Front Biosci (Landmark Ed). 2014. PMID: 24896331 Review.
-
Liu Q, Graeff R, Kriksunov IA, Jiang H, Zhang B, Oppenheimer N, Lin H, Potter BV, Lee HC, Hao Q. Liu Q, et al. J Biol Chem. 2009 Oct 2;284(40):27637-45. doi: 10.1074/jbc.M109.031005. Epub 2009 Jul 28. J Biol Chem. 2009. PMID: 19640846 Free PMC article.
-
CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity.
Malavasi F, Deaglio S, Ferrero E, Funaro A, Sancho J, Ausiello CM, Ortolan E, Vaisitti T, Zubiaur M, Fedele G, Aydin S, Tibaldi EV, Durelli I, Lusso R, Cozno F, Horenstein AL. Malavasi F, et al. Mol Med. 2006 Nov-Dec;12(11-12):334-41. doi: 10.2119/2006–00094.Malavasi. Mol Med. 2006. PMID: 17380201 Free PMC article. Review.
-
Ceni C, Muller-Steffner H, Lund F, Pochon N, Schweitzer A, De Waard M, Schuber F, Villaz M, Moutin MJ. Ceni C, et al. J Biol Chem. 2003 Oct 17;278(42):40670-8. doi: 10.1074/jbc.M301196200. Epub 2003 Aug 8. J Biol Chem. 2003. PMID: 12909645
Cited by
-
Díaz-Tejedor A, Lorenzo-Mohamed M, Puig N, García-Sanz R, Mateos MV, Garayoa M, Paíno T. Díaz-Tejedor A, et al. Cancers (Basel). 2021 Mar 17;13(6):1353. doi: 10.3390/cancers13061353. Cancers (Basel). 2021. PMID: 33802806 Free PMC article. Review.
-
Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma.
Radocha J, van de Donk NWCJ, Weisel K. Radocha J, et al. Cancers (Basel). 2021 Mar 29;13(7):1571. doi: 10.3390/cancers13071571. Cancers (Basel). 2021. PMID: 33805481 Free PMC article. Review.
-
Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis.
Palladini G, Milani P, Malavasi F, Merlini G. Palladini G, et al. Cells. 2021 Mar 4;10(3):545. doi: 10.3390/cells10030545. Cells. 2021. PMID: 33806310 Free PMC article. Review.
-
Immunotherapy: A New Approach to Treating Multiple Myeloma with Daratumumab and Elotuzumab.
Afifi S, Michael A, Lesokhin A. Afifi S, et al. Ann Pharmacother. 2016 Jul;50(7):555-68. doi: 10.1177/1060028016642786. Epub 2016 Apr 15. Ann Pharmacother. 2016. PMID: 27083916 Free PMC article. Review.
-
Cosker F, Cheviron N, Yamasaki M, Menteyne A, Lund FE, Moutin MJ, Galione A, Cancela JM. Cosker F, et al. J Biol Chem. 2010 Dec 3;285(49):38251-9. doi: 10.1074/jbc.M110.125864. Epub 2010 Sep 24. J Biol Chem. 2010. PMID: 20870729 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous